Janus Henderson Group
ALXO icon

Janus Henderson Group’s ALX Oncology ALXO Stock Holding History

Janus Henderson Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-918,908
Closed -$19.8M – 2648
2021
Q4 		$19.8M Sell
918,908
-106,491
-10% -$4.59M 0.01% 794
2021
Q3 		$75.7M Sell
1,025,399
-198,214
-16% -$13.2M 0.03% 432
2021
Q2 		$66.9M Sell
1,223,613
-148,263
-11% -$8.87M 0.03% 488
2021
Q1 		$97.5M Sell
1,371,876
-256,323
-16% -$20.2M 0.04% 379
2020
Q4 		$136M Buy
1,628,199
+1,198,397
+279% +$72.1M 0.06% 298
2020
Q3 		$16.2M Buy
+429,802
New +$16.9M 0.01% 753

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Janus Henderson Group's ALXO Position: Q1 2022 in Review

Janus Henderson Group sold out of ALX Oncology (ALXO) in Q1 2022, closing a stake of 918,908 shares — an estimated $19.8M sold.

Janus Henderson Group first reported a position in ALXO in Q3 2020 and held it in 6 quarters. The position peaked at $136M in Q4 2020. 96 funds tracked by Wall St. Rank hold ALXO as of Q1 2022.

  • Janus Henderson Group reported no remaining ALX Oncology position as of Q1 2022 after selling out during the quarter.
  • Janus Henderson Group sold 918,908 ALX Oncology shares in Q1 2022, an estimated $19.8M.
  • Janus Henderson Group first reported a position in ALX Oncology in Q3 2020 and held it in 6 quarters.
  • Janus Henderson Group's ALX Oncology position peaked at $136M in Q4 2020.
  • 96 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2022.

Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.